Literature DB >> 7846905

En bloc resection for extensive hepatocellular carcinoma: is it advisable?

K S Jeng1, B F Chen, H J Lin.   

Abstract

When the adjacent organ is partially invaded by a hepatocellular carcinoma (HCC), whether to go on an aggressive resection is a difficult but challenging problem. To investigate the worth of en bloc resections, a retrospective controlled study was conducted. During a 9-year period, nine patients (seven men, two women: group I) who had HCC with invasions to extrahepatic adjacent organs had undergone en bloc resections. The adjacent organs included diaphragm (eight cases), adrenal gland (two cases), abdominal wall (one case), and spleen (one case). The patients selected for en bloc resections were those with a solitary tumor without evidence of vascular invasion or intravascular tumor thrombi, daughter nodule(s), or distant metastasis. The evidence was based on preoperative evaluation by ultrasonography, computed tomography, arteriography, and intraoperative ultrasonography. Eighteen matched patients with HCC but no involvement of neighboring organs were selected as controls (14 men, 4 women: group II). Though patients of group I had wider invasion of HCC and more extensive resection, their surgical morbidity, mortality, hospital mortality, disease-free interval, and survival time were similar to those of group II, who had more limited HCC and resections. Eighteen months after operation, the HCC recurrence rate was 44% and 41% in groups I and II, respectively, and the percent survivals were 71% and 63%, respectively. We suggest that in cases of large HCC with local invasion to neighboring organs, aggressive en bloc resection is recommended after appropriate patient selection.

Entities:  

Mesh:

Year:  1994        PMID: 7846905     DOI: 10.1007/bf00299079

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

1.  Long-term prognosis of surgical patients with hepatocellular carcinoma.

Authors:  N Kawano; Y Ohmori; S Inoue; T Nagao; Y Morioka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection.

Authors:  Y Yoshida; T Kanematsu; T Matsumata; K Takenaka; K Sugimachi
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

3.  Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival.

Authors:  E Okamoto; N Tanaka; N Yamanaka; A Toyosaka
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

4.  Factors influencing primary liver cancer resection survival rate.

Authors:  Z Y Tang; Y Q Yu; X D Zhou; Q M Chen
Journal:  Chin Med J (Engl)       Date:  1981-11       Impact factor: 2.628

5.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.

Authors:  T Nagao; S Inoue; S Goto; T Mizuta; Y Omori; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

6.  Extended hepatectomy for hepatocellular carcinoma.

Authors:  S al-Hadeedi; T K Choi; J Wong
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

7.  Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period.

Authors:  K Ozawa; T Takayasu; K Kumada; Y Yamaoka; K Tanaka; N Kobayashi; T Inamoto; Y Shimahara; K Mori; K Honda
Journal:  Am J Surg       Date:  1991-06       Impact factor: 2.565

8.  Major hepatic resection for neoplasia: personal experience in 108 patients.

Authors:  J G Fortner; D K Kim; B J Maclean; M K Barrett; S Iwatsuki; A D Turnbull; W S Howland; E J Beattie
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

9.  Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications.

Authors:  H C Hsu; T T Wu; M Z Wu; J C Sheu; C S Lee; D S Chen
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

10.  Prognostic significance of histologic findings in resected small hepatocellular carcinoma.

Authors:  C S Lee; L Y Hwang; R P Beasley; H C Hsu; H S Lee; T Y Lin
Journal:  Acta Chir Scand       Date:  1988-03
View more
  13 in total

1.  Surgical impacts of an en bloc resection of the diaphragm for hepatocellular carcinoma with gross diaphragmatic involvement.

Authors:  Yo-ichi Yamashita; Kazutoyo Morita; Tomohiro Iguchi; Eiji Tsujita; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

2.  Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs.

Authors:  Yan-Ming Zhou; Cheng-Jun Sui; Bin Li; Feng Xu; Tong Kan; Jia-Mei Yang
Journal:  Can J Surg       Date:  2012-08       Impact factor: 2.089

3.  Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma.

Authors:  C M Lo; E C Lai; C L Liu; S T Fan; J Wong
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences?

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Shou-Chuan Shih; Chin-Roa Kao; Po-Chuan Wang; Chih-Zen Chen; Wen-Hsing Chang; Horng-Yuan Wang; Li-Rung Shyung
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

5.  Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma.

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Shou-Chuan Shih; Chih-Roa Kao; Wen-Hsing Chang; Horng-Yuan Wang; Po-Chuan Wang; Tsang-En Wang; Li-Rung Shyung; Chih-Zen Chen
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study.

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Po-Chuan Wang; Shou-Chuan Shih; Wen-Hsing Chang; Horng-Yuan Wang; Chung-Chu Chen; Li-Rung Shyung
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?

Authors:  Kuo-Shyang Jeng; I-Shyan Sheen; Yi-Ching Wang; Shu-Ling Gu; Chien-Ming Chu; Shou-Chuan Shih; Po-Chuan Wang; Wen-Hsing Chang; Horng-Yuan Wang
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Role of liver transplantation in the treatment of unresectable liver cancer.

Authors:  R Pichlmayr; A Weimann; K J Oldhafer; H J Schlitt; J Klempnauer; A Bornscheuer; A Chavan; E Schmoll; H Lang; G Tusch
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

9.  Should diaphragmatic involvement preclude resection of large hepatic tumors?

Authors:  Nikolaos Arkadopoulos; Maria A Kyriazi; Apostolos Perelas; Kassiani Theodoraki; Evangelia Papantoni; Panagiotis Kokoropoulos; Nikolaos Danias; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

10.  Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?

Authors:  I-Shyan Sheen; Kuo-Shyang Jeng; Shou-Chuan Shih; Po-Chuan Wang; Wen-Hsiung Chang; Horng-Yuan Wang; Li-Rung Shyung; Shee-Chan Lin; Chin-Roa Kao; Yi-Chun Tsai; Tsu-Yen Wu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.